[A Case of Gastric Metastasis from Breast Cancer Detected 12 Years after Surgery].
Gastric metastasis of breast cancer is clinically rare and its diagnosis is often delayed because of the difficulty in differentiating it from primary gastric cancer.
APA
Kimura Y, Terasawa R, et al. (2025). [A Case of Gastric Metastasis from Breast Cancer Detected 12 Years after Surgery].. Gan to kagaku ryoho. Cancer & chemotherapy, 52(12), 881-883.
MLA
Kimura Y, et al.. "[A Case of Gastric Metastasis from Breast Cancer Detected 12 Years after Surgery].." Gan to kagaku ryoho. Cancer & chemotherapy, vol. 52, no. 12, 2025, pp. 881-883.
PMID
41437605
Abstract
Gastric metastasis of breast cancer is clinically rare and its diagnosis is often delayed because of the difficulty in differentiating it from primary gastric cancer. Here, we report a case of gastric metastasis identified 12 years after surgery for left-sided breast cancer. Gastrointestinal symptoms prompted an upper gastrointestinal endoscopy, which revealed an elevated gastric lesion. Immunohistochemical staining of the lesion showed positivity for CK7, GATA-3, mammaglobin, and GCDFP-15, and negativity for CK20, leading to the diagnosis of gastric metastasis from breast cancer. When gastrointestinal symptoms occur in patients with a history of breast cancer, it is important to consider gastric metastasis in the differential diagnosis and perform a thorough evaluation, including immunohistochemical analysis.
MeSH Terms
Humans; Stomach Neoplasms; Breast Neoplasms; Female; Time Factors; Middle Aged
같은 제1저자의 인용 많은 논문 (5)
- Factors Associated With Nonadherence to S-1 in Docetaxel+S-1(DS) Therapy, an Adjuvant Treatment for Gastric Cancer.
- Diagnostic and decision-making disparities in precision oncology in thoracic malignancies with interstitial pneumonia: A real-world cohort study.
- Outcomes in Health-Related Quality of Life and Impact of Urinary Incontinence on Health-Related Quality of Life 7 Years After Robot-Assisted Radical Prostatectomy.
- Real-time assessment of circulating tumor cells refines the indication for HER2-targeted therapy in metastatic gastric cancer.
- Short-term outcomes of a phase II trial of perioperative capecitabine plus oxaliplatin therapy for advanced gastric cancer with extensive lymph node metastases (OGSG1701).